Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.
Cidara Therapeutics has raised $339.0M in total funding. The most recent round was Grant. The last funding was announced in October 2025.
Cidara Therapeutics's investors include RA Capital Management, Vivo Capital, TCG Crossover, Adage Capital Management, Perceptive Advisors.
Cidara Therapeutics is headquartered in San Diego, United States.
Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.
Cidara Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cidara Therapeutics — Funding & Investors." VCBacked, October 3, 2025, https://www.vcbacked.co/company/cidara-therapeutics. Accessed October 30, 2026.
VCBacked. (2025). Cidara Therapeutics — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/cidara-therapeutics
{{cite web |title=Cidara Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cidara-therapeutics |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated